Polymedication
Polymedication has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Apr 20, 2023: “Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditions”.
1 paper studies it1 findingUpdated
“polymedication (HR = 2.6; 95% CI = 2.0-3.3)”
- 1 lab in 1 country
- Humans1
What did studies of Polymedication find?
1Studies of Polymedication measured 1 outcome; the most studied are survival (1 study).
Survival
downin humans1HR 2.6
1 study
Survival
downin humans1HR 2.6
Polymedication decreases survival in humans (HR 2.6, 95% CI 2.0-3.3).
“polymedication (HR = 2.6; 95% CI = 2.0-3.3)”
Humansin patients with chronic conditions
BMC primary care
Latest
BMC Primary Care
Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditions
Cohort study of 9,866 peoplePopulations